November 27, 2025
The Olympics Don’t Want This… But Investors Do: Enhanced Games to List on Public Markets

The Enhanced Games – a sports league that openly allows performance-enhancing drugs – has officially announced its intention to go public via a SPAC.

If you’re unfamiliar, The Enhanced Games is the first sports organization in history to say out loud what the performance world has tiptoed around for decades: human enhancement is inevitable. 

Athletes already train with AI coaching, wearable biometric tech, gene-targeted diets, neurostimulation, blood-oxygen optimization, and, yes, pharmaceuticals.  And while traditional athletic organizations and agencies, such as the IOC and WADA, have spent decades fighting doping, The Enhanced Games has essentially said: “Fine. If you can’t stop it, we’ll build an entire league around it.”

So instead of pretending the future isn’t happening, The Enhanced Games is turning it into a business model.  And I’m here for it.

This Could be Huge

Let’s be honest: mainstream sports have become hyper-commercialized, tightly regulated, and algorithmically sanitized. The Enhanced Games is taking the opposite approach:  raw spectacle, extreme performance, and a fan base that wants to see where human capability can really go.

And from an investment standpoint, there’s a lot here that makes this look attractive.

  • Zero Legacy Baggage: No outdated drug policies, no aging federations, no bureaucratic overhead.  Just pure entertainment engineered for the modern attention economy.
  • Built for Streaming: This is the TikTok / YouTube Olympics.  Short, explosive, high-impact events built to go viral.
  • Athlete Magnetism: Elite athletes who’ve been banned, sidelined, or choked by bureaucracy now have a place to compete and earn a nice paycheck. 
  • Pharma, AI, and Biohacking Tie-Ins: Big-money sponsors aren’t just brands anymore.  They’re labs, biotech firms, wearable companies, AI coaching platforms. For them, this is a human enhancement showcase that will put the asses in the seats. 

Of course, the critics are furious.

Traditional sports organizations are already sounding alarms, medical ethicists are clutching pearls, and politicians will surely poke at it. But the truth is, every major disruption of the past 30 years began exactly like this:

  • Uber – “illegal”

  • Bitcoin – “dangerous”

  • Esports – “not real sports”

  • MMA – “barbaric”

  • Tesla – “a folly”

And now, they’re multi-billion-dollar industries, global institutions, or cultural cornerstones.

Make no mistake: The Enhanced Games is controversial, colorful, bold, and unapologetic.  This is exactly the kind of thing the market loves once it gets momentum.  And it’s exactly the kind of thing I love to profit from.

A Cultural and Financial Phenomenon

Sports is a $500+ billion market.

Biotech is a $1.6 trillion market.


Human performance is an infinite market.

The Enhanced Games sits right at the intersection of all three,  and now it’s giving retail investors a front-row seat.

To be honest, you don’t have to love the concept.  You don’t even have to agree with it.  But from an investment standpoint, ignoring a first-of-its-kind cultural and financial phenomenon is almost always the wrong move.

While I’m not typically a fan of SPACs, if this one is structured right, I’m a buyer.  There’s just too much potential here to ignore. 

The company is expected to trade on the Nasdaq under the symbol “ENHA.”  We’ll keep you posted as more develops.

In the meantime, if you’re curious to know how disruptions in sports entertainment work out for investors, look no further than TKO Group Holdings (NYSE: TKO), the company that owns the WWE and the UFC. 

There’s a lot of money to be made in sports entertainment, and The Enhanced Games is going to get a giant piece of this action in the coming years.  Because underneath the shock factor is a business model with multiple high-potential monetization channels, most of which aren’t even available to traditional sports organizations.

This is where The Enhanced Games transforms from “provocative idea” into a legitimate revenue engine.

Let’s break it down.

Broadcasting and Streaming Rights

This is the big one.

Traditional sports leagues make the majority of their revenue from media rights:

  • NFL: ~$110 billion

  • Olympics: ~$7.65 billion (NBC alone)

  • UFC: ~$1.5 billion

  • F1: ~$1.1 billion

Enhanced Games is tailor-made for:

  • short-form streaming

  • high-engagement social video

  • global digital distribution

  • direct-to-consumer subscription models

Because the content is shocking, novel, and viral, it has a stronger natural advantage than most legacy sports.

Estimated long-term revenue potential: $250M to $1B+ annually based on mixed media/streaming packages.

Sponsorships and Partnerships

Enhanced Games isn’t just attracting sports brands, it's attracting:

  • biotech companies

  • pharmaceutical firms

  • neurotech startups

  • wearable and biometrics companies

  • AI fitness & training platforms

  • longevity and hormone clinics

  • biohacking brands

This creates an entirely new sponsorship category unavailable to traditional regulated sports.

Think of it as the CES of human performance – a massive showcase for enhancement technology.

Estimated revenue potential: $100M to $300M annually once mature.

Athlete Participation and Revenue Licensing

Enhanced Games is creating a model where athletes are compensated more transparently and can license their:

  • likeness

  • performance data

  • biometrics

  • enhancement protocols

  • personalized training systems

That means Enhanced Games gets licensing revenue and athletes get revenue share. This is not only good business ethics, but also smart business. 

This can evolve into an entire IP ecosystem around the athletes themselves.

Estimated revenue: $25M to $150M annually (depending on scale of athlete branding).

Merchandising and Consumer Products

This includes:

  • apparel

  • supplements

  • books and documentaries

  • NFTs/digital collectibles

  • athlete-branded enhancement programs

  • data-driven training apps

  • fan wear

Because the league isn’t limited by IOC/WADA restrictions, it can partner with enhancement-focused brands that would never be allowed in conventional sports.

Estimated revenue: $50M to $200M annually

Live Event Ticket Sales and VIP Experiences

While much of the audience will be digital, the live factor will still be massive.

Events will be designed like:

  • UFC fight nights

  • F1 Grand Prix weekends

  • WWE spectacle events

  • Technology expos

  • Sports science conferences

Potential revenue sources:

  • stadium ticketing

  • VIP passes

  • athlete meet-and-greets

  • biohacking workshops

  • sponsor-themed fan zones

Estimated revenue potential: $50M to $150M per year

Betting and Gambling Partnerships

Let’s be real: the betting markets are going to explode for this.

Enhancement introduces:

  • new performance variables

  • unprecedented record-breaking potential

  • unpredictable outcomes

Sportsbooks love unpredictability. Fans love it even more.

Enhanced Games can monetize through:

  • official sportsbook partnerships

  • data licensing (real-time biometrics, etc.)

  • enhanced analytics feeds

  • wagering sponsorships

This is one of the most lucrative areas in modern sports.

Estimated revenue potential: $100M to $300M annually

Scientific, Biotech and Data Licensing

This is a revenue stream that no other sports league has.

Enhanced Games will have access to:

  • athlete performance data

  • recovery data

  • biomarker profiles

  • enhancement outcomes

  • drug protocol efficacy

  • neuromuscular response patterns

  • AI-coached training telemetry

Pharma, biotech, wearable tech, and even military human-performance divisions will pay handsomely for anonymized and aggregated data.

Some of this data has value in:

  • drug development

  • medical research

  • sports science

  • aging and longevity studies

  • military conditioning

  • occupational health

This might ultimately become one of the most profitable pieces of the business.

Estimated revenue potential: $200M to $500M+ annually

Global Franchise and International Spinoff Leagues

If the main league succeeds, expect:

  • regional events

  • franchised teams

  • national “enhanced games” competitions

  • global tour circuits

  • Netflix-style documentary deals

  • cross-brand athletic events

Think UFC + Olympics + F1 + CES in one hybridized model.

Franchising alone could become a billion-dollar pillar.

Estimated revenue: $250M to $750M annually

Tech Licensing

If The Enhanced Games develops things like proprietary training tech, biomonitoring systems, enhancement protocols, real-time AI coaching, and enhanced athlete safety systems, then the league can license this technology worldwide.

Just like how Formula 1 teams spin off engine technology, sensors, data systems, and aerodynamic designs, The Enhanced Games could license:

  • sports science innovations

  • enhancement monitoring systems

  • performance-tracking software

  • augmented reality fan tools

This is the long-game revenue line.

Revenue potential: $100M to $400M annually

Total Potential Annual Revenue

If the Enhanced Games matures like UFC or F1, and combines biotech, AI, data, and sports entertainment, it’s entirely plausible that it could pull in between $1 billion and $4.2 billion a year.  

Obviously, this is dependent upon adoption, media deals, and global expansion.  But if it plays out the way I think it will, this is a growth trajectory that is beyond appetizing for retail investors looking to get in early on the next sports entertainment juggernaut. 

Invest accordingly. 

Show Disclaimer

We are not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authorities. Further, our owners, employees, agents are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authorities.

The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of our websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.

Disclaimer: Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and our partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing herein constitutes a recommendation respecting the particular security illustrated.